Treating diabetic ulcers

Expert Opinion on Pharmacotherapy

Volumn 12, Issue 4, 2011, Pages 593-606

  Tecilazich, Francesco ^a   Dinh, Thanh ^a   Veves, Aristidis ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Chronic inflammation; Diabetes mellitus; Diabetic foot ulcer; Endothelial dysfunction; Growth factors; Neuropeptides; Peripheral neuropathy; Peripheral vascular disease; Wound healing

Indexed keywords

ALPHA INTERMEDIN; CALCITONIN GENE RELATED PEPTIDE; CORTICOTROPIN RELEASING FACTOR; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; NERVE GROWTH FACTOR; NEUROPEPTIDE Y; NEUROTENSIN; PLATELET DERIVED GROWTH FACTOR; SUBSTANCE P; VASCULOTROPIN;

ANTIBIOTIC THERAPY; CELL THERAPY; CHRONIC INFLAMMATION; DEBRIDEMENT; DIABETIC FOOT; ENDOTHELIAL PROGENITOR CELL; EXTRACORPOREAL LITHOTRIPSY; GENE THERAPY; HUMAN; HYPERBARIC OXYGEN; INFECTION; MUSCLE METABOLISM; NONHUMAN; OXYGENATION; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; REVASCULARIZATION; REVIEW; VACUUM ASSISTED CLOSURE; WOUND CARE; WOUND HEALING; WOUND HEALING IMPAIRMENT;

AMPUTATION; ANIMALS; DIABETIC FOOT; HOSPITALIZATION; HUMANS; PATIENT COMPLIANCE; WOUND HEALING;

EID: 79951664627     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.2011.530658     Document Type: Review

References (103)

1. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53 (Pubitemid 38579764)
2. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care 1998;21:1138-45 (Pubitemid 28368522)
3. Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999;22:382-7 (Pubitemid 29106890)
4. Gibbons GEG. Infection of the diabetic foot. In: Kozak GHC, Rowbotham J, Wheelock F, editors, Management of diabetic foot problems. Saunders, Philadelphia; 1984. P. 97-102
5. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 1990;13:513-21 (Pubitemid 20145956)
6. Apelqvist J, Bakker K, van Houtum WH, et al. International consensus and practical guidelines on the management and the prevention of the diabetic foot. International Working Group on the Diabetic Foot. Diabetes Metab Res Rev 2000;16(Suppl 1):S84-92
7. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet 2005;366:1736-43 (Pubitemid 41587454)
8. Loots MA, Lamme EN, Zeegelaar J, et al. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol 1998;111:850-7 (Pubitemid 28509329)
9. Lazarus GS, Cooper DM, Knighton DR, et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol 1994;130:489-93 (Pubitemid 24123372)
10. Shaw JE, Boulton AJ. The pathogenesis of diabetic foot problems: an overview. Diabetes 1997;46(Suppl 2):S58-61
11. Boulton A. Late sequelae of diabetic neuropathy. In: Boulton A, editor, Diabetic neuropathy. Marius. Press., Lancaster; 1997. p. 63-76
12. Rosa JS, Flores RL, Oliver SR, et al. Sustained IL-1alpha, IL-4, and IL-6 elevations following correction of hyperglycemia in children with type 1 diabetes mellitus. Pediatr Diabetes 2008;9:9-16
13. Bogdanski P, Pupek-Musialik D, Dytfeld J, et al. Influence of insulin therapy on expression of chemokine receptor CCR5 and selected inflammatory markers in patients with type 2 diabetes mellitus. Int J Clin Pharmacol Ther 2007;45:563-7 (Pubitemid 47527456)
14. Tilg H, Moschen AR. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med 2008;14:222-31 (Pubitemid 351481853)
15. Hatanaka E, Monteagudo PT, Marrocos MS, Campa A. Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes. Clin Exp Immunol 2006;146:443-7 (Pubitemid 44722162)
16. Fisman EZ, Adler Y, Tenenbaum A. Biomarkers in cardiovascular diabetology: interleukins and matrixins. Adv Cardiol 2008;45:44-64
17. Mastej K, Adamiec R. Neutrophil surface expression of CD11b and CD62L in diabetic microangiopathy. Acta Diabetol 2008;45:183-90
18. Stegenga ME, van der Crabben SN, Dessing MC, et al. Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans. Diabet Med 2008;25:157-64 (Pubitemid 351293406)
19. Oncul O, Yildiz S, Gurer US, et al. Effect of the function of polymorphonuclear leukocytes and interleukin-1 beta on wound healing in patients with diabetic foot infections. J Infect 2007;54:250-6 (Pubitemid 46238168)
20. Ochoa O, Torres FM, Shireman PK. Chemokines and diabetic wound healing. Vascular 2007;15:350-5 (Pubitemid 350305401)
21. Menzoian JO, LaMorte WW, Paniszyn CC, et al. Symptomatology and anatomic patterns of peripheral vascular disease: differing impact of smoking and diabetes. Ann Vasc Surg 1989;3:224-8
22. Arora S, Pomposelli F, LoGerfo FW, Veves A. Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not completely after successful lower extremity revascularization. J Vasc Surg 2002;35:501-5 (Pubitemid 44718594)
23. Caballero AE, Arora S, Saouaf R, et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 1999;48:1856-62 (Pubitemid 29415208)
24. Veves A, Akbari CM, Primavera J, et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 1998;47:457-63 (Pubitemid 28104210)
25. Szabo C, Zanchi A, Komjati K, et al. Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation 2002;106:2680-6 (Pubitemid 35364922)
26. Caselli A, Rich J, Hanane T, et al. Role of C-nociceptive fibers in the nerve axon reflex-related vasodilation in diabetes. Neurology 2003;60:297-300 (Pubitemid 36152026)
27. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999;79:1283-316 (Pubitemid 29473317)
28. Clark RA. Regulation of fibroplasia in cutaneous wound repair. Am J Med Sci 1993;306:42-8 (Pubitemid 23198472)
29. Abraham J, Reed T. Reshaping the carcinogenic risk assessment of medicines: international harmonization for drug safety, industry/regulator efficiency or both? Soc Sci Med 2003;57:195-204 (Pubitemid 36582663)
30. Risau W. Angiogenic growth factors. Prog Growth Factor Res 1990;2:71-9 (Pubitemid 120040341)
31. Gale NW, Yancopoulos GD. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 1999;13:1055-66 (Pubitemid 29233137)
32. Rafii S, Meeus S, Dias S, et al. Contribution of marrow-derived progenitors to vascular and cardiac regeneration. Semin Cell Dev Biol 2002;13:61-7 (Pubitemid 35418315)
33. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-7 (Pubitemid 27087709)
34. Takahashi T, Kalka C, Masuda H, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5:434-8 (Pubitemid 29180584)
35. Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353:999-1007 (Pubitemid 41262334)
36. Sata M, Saiura A, Kunisato A, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002;8:403-9 (Pubitemid 34407037)
37. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infracted myocardium. Nature 2001;410:701-5 (Pubitemid 32290358)
38. Kaushal S, Amiel GE, Guleserian KJ, et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 2001;7:1035-40 (Pubitemid 32937384)
39. Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000;97:3422-7 (Pubitemid 30183318)
40. Majka SM, Jackson KA, Kienstra KA, et al. Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration. J Clin Invest 2003;111:71-9 (Pubitemid 36134850)
41. Grant MB, May WS, Caballero S, et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med 2002;8:607-12 (Pubitemid 34633439)
42. Otani A, Kinder K, Ewalt K, et al. Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat Med 2002;8:1004-10 (Pubitemid 35033705)
43. Young PP, Hofling AA, Sands MS. VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients. Proc Natl Acad Sci USA 2002;99:11951-6 (Pubitemid 34994505)
44. Lyden D, Hattori K, Dias S, et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001;7:1194-201 (Pubitemid 33063774)
45. Aicher A, Zeiher AM, Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension 2005;45:321-5 (Pubitemid 40315795)
46. Rafii S, Avecilla S, Shmelkov S, et al. Angiogenic factors reconstitute hematopoiesis by recruiting stem cells from bone marrow microenvironment. Ann N Y Acad Sci 2003;996:49-60 (Pubitemid 36706586)
47. Boska M. Estimating the ATP cost of force production in the human gastrocnemius/soleus muscle group using 31P MRS and 1H MRI. NMR Biomed 1991;4:173-81
48. Greenman RL, Panasyuk S, Wang X, et al. Early changes in the skin microcirculation and muscle metabolism of the diabetic foot. Lancet 2005;366:1711-17 (Pubitemid 41587450)
49. Greenman RL, Rakow-Penner R. Evaluation of the RF field uniformity of a double-tuned 31P/1H birdcage RF coil for spin-echo MRI/MRS of the diabetic foot. J Magn Reson Imaging 2005;22:427-32 (Pubitemid 41298332)
50. Pomposelli FB, Kansal N, Hamdan AD, et al. A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases. J Vasc Surg 2003;37:307-15 (Pubitemid 36236907)
51. Greenman RL. Quantification of the 31P metabolite concentration in human skeletal muscle from RARE image intensity. Magn Reson Med 2004;52:1036-42 (Pubitemid 39453276)
52. Nakamura M, Kawahara M, Morishige N, et al. Promotion of corneal epithelial wound healing in diabetic rats by the combination of a substance P-derived peptide (FGLM-NH2) and insulin-like growth factor-1. Diabetologia 2003;46:839-42 (Pubitemid 36831413)
53. Movafagh S, Hobson JP, Spiegel S, et al. Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors. FASEB J 2006;20:1924-6
54. Ekstrand AJ, Cao R, Bjorndahl M, et al. Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing. Proc Natl Acad Sci USA 2003;100:6033-8 (Pubitemid 36576926)
55. Kuo LE, Abe K, Zukowska Z. Stress, NPY and vascular remodeling: implications for stress-related diseases. Peptides 2007;28:435-40 (Pubitemid 46176248)
56. Delgado AV, McManus AT, Chambers JP. Exogenous administration of Substance P enhances wound healing in a novel skin-injury model. Exp Biol Med (Maywood) 2005;230:271-80 (Pubitemid 40478252)
57. Zukowska Z, Grant DS, Lee EW. Neuropeptide Y: a novel mechanism for ischemic angiogenesis. Trends Cardiovasc Med 2003;13:86-92 (Pubitemid 36173862)
58. Hokfelt T, Kellerth JO, Nilsson G, Pernow B. Substance p: localization in the central nervous system and in some primary sensory neurons. Science 1975;190:889-90
59. Harrison S, Geppetti P. Substance p. Int J Biochem Cell Biol 2001;33:555-76
60. Khawaja AM, Rogers DF. Tachykinins: receptor to effector. Int J Biochem Cell Biol 1996;28:721-38 (Pubitemid 26181860)
61. Lindberger M, Schroder HD, Schultzberg M, et al. Nerve fibre studies in skin biopsies in peripheral neuropathies. I. Immunohistochemical analysis of neuropeptides in diabetes mellitus. J Neurol Sci 1989;93:289-96 (Pubitemid 19280549)
62. Pernow B. Substance P. Pharmacol Rev 1983;35:85-141
63. Wallengren J, Badendick K, Sundler F, et al. Innervation of the skin of the forearm in diabetic patients: relation to nerve function. Acta Derm Venereol 1995;75:37-42
64. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, et al. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res 1998;83:187-95 (Pubitemid 28354463)
65. Andersson D, Brunkwall J, Bergqvist D, Edvinsson L. Diminished contractile responses to neuropeptide Y of arteries from diabetic rabbits. J Auton Nerv Syst 1992;37:215-22
66. Maggi CA. Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves. Prog Neurobiol 1995;45:1-98
67. Toda M, Suzuki T, Hosono K, et al. Roles of calcitonin gene-related peptide in facilitation of wound healing and angiogenesis. Biomed Pharmacother 2008;62:352-9 (Pubitemid 351899104)
68. Oltman CL, Davidson EP, Coppey LJ, et al. Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction. Diabetes Obes Metab 2009;11:223-33
69. Sheehan P, Jones P, Caselli A, et al. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care 2003;26:1879-82 (Pubitemid 36929137)
70. Steed DL, Donohoe D, Webster MW, Lindsley L. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. J Am Coll Surg 1996;183:61-4 (Pubitemid 26234895)
71. Falanga V, Sabolinski M. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen 1999;7:201-7 (Pubitemid 29439206)
72. Armstrong DG, Nguyen HC, Lavery LA, et al. Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care 2001;24:1019-22 (Pubitemid 33716369)
73. Birke JA, Fred B, Krieger LA, Sliman K. The effectiveness of an accommodative dressing in offloading pressure over areas of previous metatarsal head ulceration. Wounds 2003;15:33-9 (Pubitemid 36299287)
74. Faries PL, Teodorescu VJ, Morrissey NJ, et al. The role of surgical revascularization in the management of diabetic foot wounds. Am J Surg 2004;187:34S-37S (Pubitemid 38625986)
75. Lipsky BA, Berendt AR, Deery HG, et al. Diagnosis and treatment of diabetic foot infections. Plast Reconstr Surg 2006;117:212S-38S (Pubitemid 44334747)
76. Field FK, Kerstein MD. Overview of wound healing in a moist environment. Am J Surg 1994;167:2S-6S
77. Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care 1998;21:822-7 (Pubitemid 28487079)
78. Muhart M, McFalls S, Kirsner RS, et al. Behavior of tissue-engineered skin: a comparison of a living skin equivalent, autograft, and occlusive dressing in human donor sites. Arch Dermatol 1999;135:913-18 (Pubitemid 29382427)
79. Veves A, Falanga V, Armstrong DG, Sabolinski ML. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 2001;24:290-5 (Pubitemid 32119127)
80. Gentzkow GD, Iwasaki SD, Hershon KS, et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 1996;19:350-4 (Pubitemid 26115458)
81. Faglia E, Clerici G, Caminiti M, et al. The role of early surgical debridement and revascularization in patients with diabetes and deep foot space abscess: retrospective review of 106 patients with diabetes. J Foot Ankle Surg 2006;45:220-6 (Pubitemid 43963536)
82. Pinzur MS. Circular fixation for the nonplantigrade Charcot foot. Hosp Pract (Minneap) 2010;38:56-62
83. Mueller MJ, Sinacore DR, Hastings MK, et al. Effect of Achilles tendon lengthening on neuropathic plantar ulcers. A randomized clinical trial. J Bone Joint Surg Am 2003;85-A:1436-45 (Pubitemid 36951126)
84. Morykwas MJ, Faler BJ, Pearce DJ, Argenta LC. Effects of varying levels of subatmospheric pressure on the rate of granulation tissue formation in experimental wounds in swine. Ann Plast Surg 2001;47:547-51 (Pubitemid 33049586)
85. Ubbink DT, Westerbos SJ, Evans D, et al. Topical negative pressure for treating chronic wounds. Cochrane Database Syst Rev 2008;3:CD001898
86. Armstrong DG, Lavery LA. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet 2005;366:1704-10 (Pubitemid 41587449)
87. Knighton DR, Halliday B, Hunt TK. Oxygen as an antibiotic. A comparison of the effects of inspired oxygen concentration and antibiotic administration on in vivo bacterial clearance. Arch Surg 1986;121:191-5 (Pubitemid 16105204)
88. Hunt TK, Pai MP. The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. Surg Gynecol Obstet 1972;135:561-7
89. Wang C, Schwaitzberg S, Berliner E, et al. Hyperbaric oxygen for treating wounds: a systematic review of the literature. Arch Surg 2003;138:272-9; discussion 80
90. Londahl M, Katzman P, Nilsson A, Hammarlund C. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care 2010;33:998-1003
91. Loots MA, Lamme EN, Mekkes JR, et al. Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation. Arch Dermatol Res 1999;291:93-9 (Pubitemid 29116523)
92. Sivan-Loukianova E, Awad OA, Stepanovic V, et al. CD34+ blood cells accelerate vascularization and healing of diabetic mouse skin wounds. J Vasc Res 2003;40:368-77 (Pubitemid 37188106)
93. Bauer SM, Goldstein LJ, Bauer RJ, et al. The bone marrow-derived endothelial progenitor cell response is impaired in delayed wound healing from ischemia. J Vasc Surg 2006;43:134-41 (Pubitemid 43083521)
94. Tepper OM, Galiano RD, Capla JM, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002;106:2781-6 (Pubitemid 35396976)
95. Lee JA, Conejero JA, Mason JM, et al. Lentiviral transfection with the PDGF-B gene improves diabetic wound healing. Plast Reconstr Surg 2005;116:532-8 (Pubitemid 41077209)
96. Lee PY, Chesnoy S, Huang L. Electroporatic delivery of TGF-beta 1 gene works synergistically with electric therapy to enhance diabetic wound healing in db/db mice. J Invest Dermatol 2004;123:791-8 (Pubitemid 39281623)
97. Saaristo A, Tammela T, Farkkila A, et al. Vascular endothelial growth factor-C accelerates diabetic wound healing. Am J Pathol 2006;169:1080-7 (Pubitemid 44411969)
98. Wang FS, Wang CJ, Chen YJ, et al. Ras induction of superoxide activates ERK-dependent angiogenic transcription factor HIF-1alpha and VEGF-A expression in shock wave-stimulated osteoblasts. J Biol Chem 2004;279:10331-7
99. Stojadinovic A, Elster EA, Anam K, et al. Angiogenic response to extracorporeal shock wave treatment in murine skin isografts. Angiogenesis 2008;11:369-80
100. Oi K, Fukumoto Y, Ito K, et al. Extracorporeal shock wave therapy ameliorates hindlimb ischemia in rabbits. Tohoku J Exp Med 2008;214:151-8 (Pubitemid 351513548)
101. Saggini R, Figus A, Troccola A, et al. Extracorporeal shock wave therapy for management of chronic ulcers in the lower extremities. Ultrasound Med Biol 2008;34:1261-71 (Pubitemid 352010464)
102. Dumfarth J, Zimpfer D, Vogele-Kadletz M, et al. Prophylactic low-energy shock wave therapy improves wound healing after vein harvesting for coronary artery bypass graft surgery: a prospective, randomized trial. Ann Thorac Surg 2008;86:1909-13
103. Lipsky BA, Berendt AR, Deery HG, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004;39:885-910 (Pubitemid 39328144)